SMS Lifesciences India Ltd - 540679 - Board Meeting Outcome for Financial Results For Quarter Ended June 30, 2022
Enclosed is the Outcome of the Board Meeting.09-08-2022
09-08-2022
SMS Lifesciences India Ltd - 540679 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On June 30, 2022.
SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 ,inter alia, to consider and approve i) unaudited financial results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2022, ii) any other item as may be decided by the Board of Directors.03-08-2022
SMS Lifesciences India Ltd - 540679 - Newspaper Advertisement (Postal Ballot)
Enclosed - copy of newspaper publications.25-07-2022
SMS Lifesciences India Ltd - 540679 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Copy of Postal Ballot Notice.25-07-2022
SMS Lifesciences India Ltd - 540679 - Calendar Of Events (Postal Ballot)
Enclosed - Event calendar related to Postal Ballot.21-07-2022
SMS Lifesciences India Ltd - 540679 - Communication To Shareholders
Request to shareholders to update their KYC details.20-07-2022
SMS Lifesciences India Ltd - 540679 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Enclosed - Compliance Certificate.14-07-2022
SMS Lifesciences India Ltd - 540679 - Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Trupti Ranjan MohantyDesignation :- Company Secretary and Compliance Officer14-07-2022
SMS Lifesciences India Ltd - 540679 - Closure of Trading Window
INTIMATION OF TRADING WINDOW CLOSURE.28-06-2022
SMS Lifesciences India Ltd - 540679 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudeepthi Gopineedi27-06-2022